InvestorsHub - NYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News

Ticker	Name	Price	Change %	Posts
AACBU	Artius II Acquisition Inc	10.08	0.00%
AACG	ATA Creativity Global	0.9787	0.00%	29
AADI	Aadi Bioscience Inc	2.05	0.00%	16
AADR	AdvisorShares Dorsey Wright ADR ETF	73.92	0.00%
AAL	American Airlines Group Inc	10.30	0.00%	36,864
AAME	Atlantic American Corporation	1.56	0.00%	29
AAOI	Applied Optoelectronics Inc	15.09	0.00%	132
AAON	AAON Inc	79.16	0.00%	11
AAPB	GraniteShares ETF Trust GraniteShares	25.83	0.00%
AAPD	Direxion Daily AAPL ETF	16.97	0.00%

Ticker	Board Name	Price	Change %	Posts (24h)
LWLG	Lightwave Logic Inc	0.9751	0.00%	133
COOP	Mr Cooper Group Inc	125.08	0.00%	181
ASII	Accredited Solutions Inc	0.0004	+33.33%	43
RDGL	Vivos Inc	0.1190	-2.44%	50
KBLB	Kraig Biocraft Laboratories Inc	0.0890	-1.72%	41
AZRH	Azure Holding Group Corp	0.1599	0.00%	20

	Board Name	Posts (24h)
	ORIONS Money Stocks	102
	Savvy Trades and Investments	52
	BBs Stock Haven	122
4	DD Support Board and Research Team	59
5	MOMOS BREAKOUT BOARD	92
6	Rigs Platinum Stock Alerts	48

Ticker	Name	Price	Change %	Market Cap	Volume ($)
BTC	Bitcoin	84,151.15	-1.20%	1,671.3B	3.9B	Message Board Quote News
ETH	Ethereum	1,856.39	-2.57%	224.2B	1.8B	Message Board Quote News
USDT	Tether USD	0.99995	0.00%	141.9B	285.9M	Message Board Quote News
XRP	Ripple	2.08	-2.80%	120.7B	961.8M	Message Board Quote News
BNB	Binance Coin	600.00	-1.86%	94.7B	419.2M	Message Board Quote News
SOL	Solana	124.20	-1.97%	60.7B	855.2M	Message Board Quote News
USDC	USD Coin	0.9999	-0.01%	56.1B	946.9M	Quote News
DOGE	Dogecoin	0.16843	-3.17%	25.0B	325.4M	Message Board Quote News
ADA	Cardano	0.6648	-1.83%	24.0B	159.8M	Message Board Quote News
TRX	TRON	0.236993	-0.35%	20.4B	99.1M	Message Board Quote News

Play Episode

5min

Proactive - Interviews for investors

Cuscal FY25 update: profit grows on stable volumes

Cuscal Limited Managing Director Craig Kennedy talked with Proactive at AIM's Small and MIdcap conference about the company’s role in Australia's financial infrastructure and its recent financial performance for the first half of FY25. Kennedy explained that Cuscal is one of only five organisations in Australia with the full suite of licensing, infrastructure, and capabilities required to offer end-to-end payment services—alongside the four major banks. The company serves a range of clients including other banks, corporates, and fintechs, as well as working with NAB’s UBank division. Kennedy emphasised Cuscal’s position as a “neutral, independent” access point to payment infrastructure. On financial performance, Kennedy said Cuscal expects to “modestly exceed the forecast in the prospectus” issued at the time of its IPO in November. He noted that the business enjoys stable, predictable revenue and has completed significant investment in areas like real-time payments and operational upgrades. As a result, the company is beginning to see operational leverage. Kennedy stated: “Mid to high single digit volume growth will translate to low double digit profit growth.” He said H1 FY25 results showed 7% volume growth and between 12% to 13% profit growth. Reflecting on sector innovation, Kennedy described Cuscal as an "airport" enabling new players—like fintechs—to create and deliver new customer experiences on top of a stable infrastructure. He also said investors view the company as a “safe harbour,” appreciating its unique market position and stable growth outlook. #Cuscal #ASXStocks #FintechAustralia #PaymentsInfrastructure #CraigKennedy #InvestorUpdates #RealTimePayments #ASXConference #FinancialServices #BankingInnovation

Proactive - Interviews for investors

Airtasker CEO on growth, AI & global expansion

Airtasker Ltd CEO Tim Fung talked with Proactive at AIM's Small and Midcap Conference about the company’s strategic focus across innovation, growth, and international expansion.** Fung outlined how Airtasker differentiates itself in the local services marketplace by operating as a community platform, where both customers and taskers set job scopes and pricing, rather than the company enforcing set rates. He emphasised Airtasker’s approach to worker empowerment, noting, *“The top people on our platform are running 150, 200 thousand dollars a year doing these kinds of jobs.”* Fung also acknowledged the challenges of the current consumer environment, pointing to Airtasker’s 14.8% revenue growth in the half as a result of lean operations and renewed brand investment. A key part of Airtasker’s strategy involves innovation across customer acquisition, user experience, and operational efficiency—highlighting its collaboration with OpenAI and use of AI tools like Copilot and Zendesk AI. Fung also discussed partnerships, including one with Visa Cash App Racing Bulls, as examples of how Airtasker showcases the diverse range of skilled work enabled by the platform. He concluded by outlining the investor case: a cash-generative, proven business model in Australia being used to fund international growth in the US and UK, offering upside potential with limited downside. #Airtasker #TimFung #ASX #GigEconomy #AIIntegration #MarketplacePlatform #SmallCapStocks #TechInnovation #FY25Strategy #ProactiveInvestors #OpenAI #GlobalExpansion #InvestorUpdates #StartupGrowth

Proactive - Interviews for investors

Thor Explorations says Douta-West discovery adds gold ounces for upcoming PFS

Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) CEO Segun Lawson talked with Proactive's Stephen Gunnion about progress at the Douta gold project in Senegal, with a specific focus on the Douta-West licence. Lawson outlined that Thor acquired the licence a year ago and has since been advancing drilling efforts there. He confirmed the company has now made a fresh discovery, which includes oxide, free-flowing, recoverable gold material. “These are wide intersections between 12 and 20 metres wide, with very good grades between 1.3 and just over 2 grams per ton,” Lawson said. He added that the anomaly runs for approximately two kilometres and could be a significant contributor to the overall economics of the project. Lawson noted that the next step is to fully drill the strike length of the discovery zone. This will allow the company to include the newly identified ounces into its mine plan and potentially enhance the preliminary feasibility study (PFS). He also highlighted that the company is not pursuing exploration for academic purposes, but rather with a clear intent to build and deliver value to shareholders. Lawson confirmed that following the completion of the drilling campaign, Thor will provide an updated timeline for the PFS. Watch the full interview for more insights, and don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for future updates. #ThorExplorations #GoldDiscovery #MiningUpdate #SenegalMining #DrillResults #DoutaProject #GoldStocks #PFS #JuniorMining #ResourceExpansion

Proactive - Interviews for investors

Opioid-Free pain relief: AFT’s global expansion strategy

AFT Pharmaceuticals Ltd Managing Director Dr Hartley Atkinson talked with Proactive at the AIM's Small and Midcap Conference about the company's unique approach to drug development, its expanding global footprint, and what lies ahead in 2025. AFT Pharmaceuticals is focused on creating pharmaceuticals "with a difference," targeting unmet needs and reducing reliance on opioids. “We don’t sell anything we don’t believe in,” said Dr Atkinson, highlighting the importance of alternatives to opioid treatments. One of the company’s key analgesic products helps avoid opioid use — a particularly timely innovation in light of the global opioid crisis. Dr Atkinson discussed the company’s core markets, with a strong presence in New Zealand and Australia, generating approximately 150 million in revenue. AFT also maintains operations in Asia and now exports to around 80 countries. The company has experienced sustained growth, having quadrupled in size over the past decade and doubled in the last five years. AFT has established six new affiliates across regions including Singapore, Hong Kong, South Africa, Canada, the UK, and Europe. Looking ahead, the company plans several product launches across Australia and New Zealand and anticipates five drug launches in China — the world’s second-largest pharmaceutical market. “For us, that’s going to be an interesting journey,” Atkinson added. #AFTPharmaceuticals #OpioidAlternatives #PharmaceuticalInnovation #ChinaPharma #DrugDevelopment #HealthcareGrowth #ASXStocks #BiotechInvesting #GlobalHealthcare #PharmaExpansion

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

U.S. Stocks Finish Volatile Session Mostly Higher

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

U.S. Stocks Finish Volatile Session Mostly Higher

Go Ad-Free